338
Views
6
CrossRef citations to date
0
Altmetric
Review Article

Retinopathy prematurity: a systematic review and meta-analysis study based on neonatal and maternal risk factors

, , &
Pages 8032-8050 | Received 28 Feb 2021, Accepted 05 Jun 2021, Published online: 13 Jul 2021

References

  • Bowe T, Nyamai L, Ademola-Popoola D, Amphornphruet A, et al. The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela. Digit J Ophthalmol. 2019;25(4):49–58.
  • Crosse V, Vans E. Prevention of retrolental fibroplasia. AMA Arch Ophthalmol. 1952;48(1):83–87.
  • Saugstad O. Oxygen and retinopathy of prematurity. J Perinatol. 2006;26(Suppl 1):S46–S50.
  • Gunn DJ, Cartwright DW, Gole GA. Incidence of retinopathy of prematurity in extremely premature infants over an 18‐year period. Clin Exp Ophthalm. 2012;40(1):93–99.
  • Shah P, Sankaran K, Aziz K, et al. Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern? J Perinatol. 2012;32(2):132–138.
  • Prpić I, Mahulja-Stamenković V, Kovačević D, et al. Prevalence of severe retinopathy of prematurity in a geographically defined population in Croatia. Coll Antropol. 2011;35(2):69–72.
  • Tavosnanska J, Carreras IM, Fariña D, et al. Morbimortalidad de recién nacidos con menos de 1500 gramos asistidos en hospitales públicos de la ciudad de Buenos Aires. Arch Argent Pediat. 2012;110(5):394–403.
  • Zin AA, Moreira MEL, Bunce C, et al. Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications. Pediatrics. 2010;126(2):e410–41e7.
  • Azami M, Jaafari Z, Rahmati S, et al. Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis. BMC Ophthalmol. 2018;18(1):83.
  • Hungi B, Vinekar A, Datti N, et al. Retinopathy of prematurity in a rural neonatal intensive care unit in South India—a prospective study. Indian J Pediatr. 2012;79(7):911–915.
  • Lundgren P, Wilde Å, Löfqvist C, et al. Weight at first detection of retinopathy of prematurity predicts disease severity. Br J Ophthalmol. 2014;98(11):1565–1569.
  • Wu C, Löfqvist C, Smith L, et al. Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2012;130(8):992–999.
  • Quinn GE. Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic. Eye Brain. 2016;8:31–36.
  • Khandekar R, Kishore H, Mansu R, et al. The status of childhood blindness and functional low vision in the Eastern Mediterranean region in 2012. Middle East Afr J Ophthalmol. 2014;21(4):336–343.
  • Tasman W. Retinopathy of prematurity: Do we still have a problem?: the Charles L. Schepens lecture. Arch Ophthalmol. 2011;129(8):1083–1086.
  • (UNDP) UNDP, editor. Human development report 2004. Oxford: UKOUP; 2004.
  • Mousavi S, Karkhaneh R, Riazi-Esfahani M, et al. Retinopathy of prematurity in infants with late retinal examination. J Ophthalmic Vis Res. 2009;4:24–28.
  • Filho JF, Eckert G, Procianoy L, et al. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye. 2009;23(1):25–30.
  • Binkhathlan A, Almahmoud L, Saleh M, et al. Retinopathy of prematurity in Saudi Arabia: incidence, risk factors, and the applicability of current screening criteria. Br J Ophthalmol. 2008;92(2):167–169.
  • Chen Y, Li X, Yin H, et al. Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China. Br J Ophthalmol. 2008;92(3):326–330.
  • Karkhaneh R, Mousavi S, Riazi-Esfahani M, et al. Incidence and risk factors of retinopathy of prematurity in a tertiary eye hospital in Tehran. Br J Ophthalmol. 2008;92(11):1446–1449.
  • Kim SJ, Port AD, Swan R, Campbell JP, et al. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63(5):618–637.
  • Villamor-Martinez E, Cavallaro G, Raffaeli G, et al. Chorioamnionitis as a risk factor for retinopathy of prematurity: an updated systematic review and meta-analysis. PLoS One. 2018;13(10):e0205838.
  • Singh HPU, Surana AN, Sha A. Retinopathy of prematurity in neonatal care unit. Int J Contemp Pediatr. 2016;3(1):234–239.
  • Theiss MB, Jْnior AG, Rodrigues MRW. Perfil epidemiológico dos recém-nascidos prematuros com retinopatia da prematuridade no Hospital Regional de São José Dr. Homero de Miranda Gomes. Rev Bras Oftalmol. 2016;75(2):109–114.
  • Kift EV, Freeman N, Cook C, et al. Retinopathy of prematurity screening criteria and workload implications at Tygerberg Children’s Hospital, South Africa: a cross-sectional study Bookmark and Share. S Afr Med J. 2016;106(6):602–606.
  • Kang EY-C, Lien R, Wang N-K, et al. Retinopathy of prematurity trends in Taiwan: a 10-year nationwide population study. Invest Ophthalmol Vis Sci. 2018;59(8):3599–3607.
  • Martínez-Cruz C, Salgado-Valladares M, Poblano A, et al. Risk factors associated with retinopathyof prematurity and visual alterations in infants with extremely low birth weight. Rev Invest Clin. 2012;64(2):136–143.
  • Hellgren G, Löfqvist C, Hansen-Pupp I, et al. Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity. Growth Horm IGF Res. 2018;39:19–24.
  • Gebeşçe A, Uslu H, Keleş E, et al. Retinopathy of prematurity: incidence, risk factors, and evaluation of screening criteria. Turk J Med Sci. 2016;46(2):315–320.
  • Gilbert C, Foster A. Childhood blindness in the context of Vision 2020-the right to sight. Bull World Health Organ. 2001;79(3):227–232.
  • Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142(6):e20183061.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W-65–W-94.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • Azami M, YektaKooshali MH, Shohani M, et al. Epidemiology of multiple sclerosis in Iran: a systematic review and meta-analysis. PLoS One. 2019;14(4):e0214738.
  • Daliri S, Safarpour H, Bazyar J, et al. The relationship between some neonatal and maternal factors during pregnancy with the prevalence of congenital malformations in Iran: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2019;32(21):3666–3674.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Wani V, Kumar N, Sabti K, et al. Results of screening for retinopathy of prematurity in a large nursery in Kuwait: incidence and risk factors. Indian J Ophthalmol. 2010;58(3):204–208.
  • Vinekar A, Mangalesh S, Jayadev C, et al. Macular edema in Asian Indian premature infants with retinopathy of prematurity: impact on visual acuity and refractive status after 1-year. Indian J Ophthalmol. 2015;63(5):432–437.
  • Rao K, Purkayastha J, Hazarika M, et al. Analysis of prenatal and postnatal risk factors of retinopathy of prematurity in a tertiary care hospital in South India. Indian J Ophthalmol. 2013;61(11):640–644.
  • Hakeem AH, Mohamed GB, Othman MF. Retinopathy of prematurity: a study of prevalence and risk factors. Middle East Afr J Ophthalmol. 2012;19(3):289–294.
  • Freitas AM, Author c, Mörschbächer R, et al. Incidence and risk factors for retinopathy of prematurity: a retrospective cohort study. Int J Retina Vitreous. 2018;4(20):20–28.
  • Gül1 F, Bülbül A. Evaluation of risk factors affecting development of retinopathy in premature infants. JAREM. 2018;8(3):171–176.
  • C S, K D, Patil AA. Retrospective study on the risk factors for retinopathy of prematurity in NICU of tertiary care hospital. Int J Contemp Pediatr. 2018;5(4):1447.
  • Lomuto C, Galina L, Brussa M, et al. Epidemiology of retinopathy of prematurity in public services from Argentina during 2008. Arch Argent Pediatr. 2010;108(1):24–30.
  • Kim C, Jung E, Kim E, et al. Chronic placental inflammation as a risk factor of severe retinopathy of prematurity. J Pathol Transl Med. 2018;52(5):290–297.
  • Akdogan M, Demirag DA, Varal IG, et al. Haemogram parameters in the development of retinopathy of prematurity. OJOPH. 2018;08(02):75–83.
  • Ahuja A, Reddy Y, Adenuga O, et al. Risk factors for retinopathy of prematurity in a district in South India: a prospective cohort study. Oman J Ophthalmol. 2018;11(1):33–37.
  • Petriçli I, Kara C, Demirel N, et al. Retinopathy of prematurity in extremely premature infants: multiple births versus single births. Turk J Med Sci. 2018;48(1):131–135.
  • Lucio KCdV, Bentlin MR, Augusto ACdL, et al. The ROPScore as a screening algorithm for predicting retinopathy of prematurity in a Brazilian population. Clinics. 2018;73:e377.
  • Silveira RC, Fortes Filho JB, Procianoy RS. Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants. Invest Ophthalmol Vis Sci. 2011;52(3):1297–1301.
  • Leng Y, Huang W, Ren G, et al. The treatment and risk factors of retinopathy of prematurity in neonatal intensive care units. BMC Ophthalmol. 2018;18(1):301–308.
  • Zasada M, Suski M, Bokiniec R, et al. An iTRAQ-based quantitative proteomic analysis of plasma proteins in preterm newborns with retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2018;59(13):5312–5319.
  • Wu T, Zhang L, Tong Y, et al. Retinopathy of prematurity among very low-birth-weight infants in China: incidence and perinatal risk factors. Invest Ophthalmol Vis Sci. 2018;59(2):757–763.
  • Cevik SG, Perente I. Retinopathy of prematurity screening criteria in Turkey’s South Marmara region. Beyoglu Eye J. 2018;3(3):133–137.
  • Sathar A, Shanavas A, Girijadevi P, et al. Risk factors of retinopathy of prematurity in a tertiary care hospital in South India. Clin Epidemiol Global Health. 2018;6(1):44–49.
  • Lu L, Ch L, Mc F, et al. Screening for retinopathy of prematurity and treatment outcome in a tertiary hospital in Hong Kong. Hong Kong Med J. 2016;23(1):41–47.
  • Arima M, Tsukamoto S, Fujiwara K, et al. Late-onset circulatory collapse and continuous positive airway pressure are useful predictors of treatment-requiring retinopathy of prematurity: a 9-year retrospective analysis. Sci Rep. 2017;7(1):3904.
  • Kistner A, Jacobson L, Östergren J, et al. Retinopathy of prematurity is associated with increased systolic blood pressure in adults who were born preterm. Neonatology. 2017;112(1):87–91.
  • Hu Y-X, Xu X-X, Shao Y, et al. The prognostic value of lymphocyte-to-monocyte ratio in retinopathy of prematurity. Int J Ophthalmol. 2017;10(11):1716–1721.
  • Coşkun Y, Dalkan C, Yabaş Ö, et al. A predictive score for retinopathy of prematurity by using clinical risk factors and serum insulin-like growth factor-1 levels. Int J Ophthalmol. 2017;10(11):1722–1727.
  • Reyes ZS, Al-Mulaabed SW, Bataclan F, et al. Retinopathy of prematurity: revisiting incidence and risk factors from Oman compared to other countries. Oman J Ophthalmol. 2017;10(1):26–32.
  • Zhu X, Zhao R, Wang Y, et al. Refractive state and optical compositions of preterm children with and without retinopathy of prematurity in the first 6 years of life. Medicine. 2017;96(45):e8565–e8566.
  • Ricard CA, Dammann CEL, Dammann O. Screening tool for early postnatal prediction of retinopathy of prematurity in preterm newborns (STEP-ROP). Neonatology. 2017;112(2):130–136.
  • Holm M, Morken T, Fichorova R, et al. Systemic inflammation-associated proteins and retinopathy of prematurity in infants born before the 28th week of gestation. Invest Ophthalmol Vis Sci. 2017;58(14):6419–6428.
  • Dorum B, Yılmaz C, Köksal N, et al. The role of serial measurements of serum insulin-like growth factor 1 levels in the development of retinopathy of prematurity. Turk Pediatri Ars. 2017;52(1):10–14.
  • Coutinho I, Pedrosa C, Mota M, et al. Retinopathy of prematurity: results from 10 years in a single neonatal intensive care unit. JPNIM. 2017;6(1):1–8.
  • Liyanage I, Perera K, Weerasekera M. A study on incidence and associated factors of retinopathy of prematurity in a tertiary care setting in Sri Lanka. Sri Lanka J Child Health. 2017;46(4):322–325.
  • Vasavada D, Sengupta S, Prajapati VK, et al. Incidence and risk factors of retinopathy of prematurity in Western India – report from a regional institute of ophthalmology. Nep J Oph. 2018;9(2):112–120.
  • Shahidullah M, Dey AC, Ahmed F, et al. Retinopathy of prematurity and its association with neonatal factors. Bangabandhu Sheikh Mujib Medical Univ J. 2017;10(1):1–4.
  • Keraan Q, Tinley C, Horn A, et al. Retinopathy of prematurity in a cohort of neonates at Groote Schuur Hospital, Cape Town, South Africa. S Afr Med J. 2016;107(1):64–69.
  • Friddle K, Yoder B, Hartnett M, et al. Can a risk factor based approach safely reduce screening for retinopathy of prematurity? Int J Pediatr. 2017;2017:9372539–9372538.
  • Timkovic J, Pokryvkova M, Janurova K, et al. Evaluation of the WinROP system for identifying retinopathy of prematurity in Czech preterm infants. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161(1):111–116.
  • Owen L, Morrison M, Hoffman R, et al. Retinopathy of prematurity: a comprehensive risk analysis for prevention and prediction of disease. PLoS One. 2017;12(2):e0171467–14.
  • Jensen A, Ying G, Huang J, et al. Postnatal serum insulin-like growth factor I and retinopathy of prematurity. Retina. 2017;37(5):867–872.
  • Ali YF, El-Morshedy S, Abdulhalim-Imam A, et al. The role of serum apelin in retinopathy of prematurity. OPTH. 2017;11:387–392.
  • Lee N, Lee H, Park S, et al. Massive pulmonary hemorrhage and severe retinopathy of prematurity in very low birth weight infants. Turk J Pediatr. 2017;59(6):636–641.
  • Dyaberi R, Mulgund U, Mulgund1 R. Analysis of retinopathy of prematurity in a tertiary care hospital. Ophthalmol Res. 2017;7(4):1–7.
  • Kumar N, Kaushik S, Grover N, et al. Retinopathy of prematurity: incidence and risk factors: a hospital based study from Shimla, Himachal Pradesh, India. Int J Res Med Sci. 2017;5(1):56–61.
  • Stutchfield C, Jain A, Odd D, et al. Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study. Eye. 2017;31(10):1451–1455.
  • Daraie G, Nooripoor S, Ashrafi A, et al. Incidence of retinopathy of prematurity and some related factors in premature infants born at Amir-al-Momeninhospital in Semnan, Iran. Koomesh. 2016;17(2):297–303.
  • Jacob MK, Sawardekar KP, Ayoub HG, et al. Validation of the existing modified screening criteria for detection of all cases of Retinopathy of Prematurity in preterm babies – 11 year study from a governorate referral hospital in Oman. Saudi J Ophthalmol. 2016;30(1):3–8.
  • Yau GSK, Lee JWY, Tam VTY, et al. Incidence and risk factors of retinopathy of prematurity from 2 neonatal intensive care units in a Hong Kong Chinese population. Asia-Pacific J Ophthalmol. 2016;5(3):185–191.
  • Klevebro S, Lundgren P, Hammar U, et al. Cohort study of growth patterns by gestational age in preterm infants developing morbidity. BMJ Open. 2016;6(11):e012872–e012879.
  • Alshaikh B, Salman O, Soliman N, et al. Pre-eclampsia and the risk of bretinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks’ gestation. BMJ. 2017;1(1):1–7.
  • Mansouri M, Hemmatpour S, Sedighiani F, et al. Factors associated with retinopathy of prematurity in hospitalized preterm infants in Sanandaj, Iran. Electron Physician. 2016;8(9):2931–2934.
  • Lynch A, Wagner B, Mandava N, et al. The relationship of novel plasma proteins in the early neonatal period with retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2016;57(11):5076–5082.
  • Li Q, Wang Z, Wang R, et al. A prospective study of the incidence of retinopathy of prematurity in China: evaluation of different screening criteria. J Ophthalmol. 2016;2016:5918736–5918738.
  • Kola M, Hacioğlu D, Erdöl H, et al. Determination of regional screening criteria for retinopathy of prematurity in the Eastern Black Sea region of Turkey. Turk J Med Sci. 2016;46(2):381–387.
  • Özdemir Ö, Özen-Tunay Z, Ergintürk-Acar D. Growth of biometric components and development of refractive errors in premature infants with or without retinopathy of prematurity. Turk J Med Sci. 2016;46(2):468–473.
  • Balakrishnan U, Shaik SJM, Manian N, et al. Screening based on incidence of severe retinopathy of prematurity in a tertiary care center in India: are Indian infants different? Int J Contemp Pediatr. 2016;3(3):847–853.
  • Gawai D, Une V, Khair B. Incidence and risk factors of retinopathy of prematurity in tertiary care centre of Western India. JMSCR. 2016;4(7):11472–11476.
  • Wang J, Chen F, He S, et al. Screening retinopathy of prematurity in extremely low birth weight infants in China and the need for earlier screening times. J Ophthalmol. 2016;2016:7065835–7065834.
  • Mitsiakos G, Papageorgiou A. Incidence and factors predisposing to retinopathy of prematurity in inborn infants less than 32 weeks of gestation. Hippokratia. 2016;20(2):121–126.
  • Messa AA, Mattos RB, Areco KCN, et al. Vision-related quality of life in children with retinopathy of prematurity. Arq Bras Oftalmol. 2015;78(4):224–228.
  • Chen Y, Feng J, Gilbert C, et al. Time at treatment of severe retinopathy of prematurity in China: recommendations for guidelines in more mature infants. PLoS One. 2015;10(2):e0116669–8.
  • Hartnett ME, Morrison MA, Smith S, et al. Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants. IOVS. 2014;55(10):6194–6202.
  • Yu C, Yi J, Yin X, et al. Correlation of interactions between NOS3 polymorphisms and oxygen therapy with retinopathy of prematurity susceptibility. Int J Clin Exp Pathol. 2015;8(11):15250–15254.
  • Hwang JH, Lee EH, Kim EA-R. Retinopathy of prematurity among very-low-birth-weight infants in Korea: incidence, treatment, and risk factors. J Korean Med Sci. 2015;30(Suppl 1):S88–S94.
  • Alizadeh Y, Zarkesh M, SoltanI-Moghadam R, et al. Incidence and risk factors for retinopathy of prematurity in North of Iran. J Ophthalmic Vis Res. 2015;10(4):424–428.
  • Kim J, Jin aY, Kim SS. Postnatal weight gain in the first two weeks as a predicting factor of severe retinopathy of prematurity requiring treatment. Korean J Pediatr. 2015;58(2):52–59.
  • Huang H-C, Yang H-I, Chou H-C, et al. Preeclampsia and retinopathy of prematurity in very-low-birth-weight infants: a population-based study. PLoS One. 2015;10(11):e0143248–e0143249.
  • Wang Z, Gao P, Bai H, et al. Postnatal weight gain in very low birth weight infants in Beijing and the risk of retinopathy of prematurity. Int J Ophthalmol. 2015;8(6):1207–1210.
  • Goswami B, Goyal M, Beri S, et al. Role of serum levels of vascular endothelial growth factor and its receptor in retinopathy of prematurity. Iran J Pediatr. 2015;25(4):e2373.
  • Ture M, Yildiz M, Karkucak M, et al. Investigation of TNF-alpha gene (G308A) and GSTP1 gene (Ile105Val) polymorphisms in Turkish patients with retinopathy of prematurity. Turk J Med Sci. 2015;45:164–169.
  • Jojić D, Predojević-Samardžić J, Mavija M, et al. The effect of oxygen therapy on the development of retinopathy of prematurity. Pedaiatr Today. 2015;11(2):144–153.
  • Al-Alawi E, Al-Omran M, Al-Bahrana E. Incidence of retinopathy of prematurity in Bahrain, 2002–2011. Middle East Afr J Ophthalmol. 2015;22(3):335–339.
  • Nakhshab M, Ahmadzadeh Amiri A, Dargahi S, et al. The incidence rate of retinopathy of prematurity and related risk factors: a study on premature neonates hospitalized in two hospitals in sari, Iran, 2014-2015. J Kerman Univ Med Sci. 2016;23(3):296–307.
  • Ozdemir1 O, Ozen-Tunay Z, Seza-Petriçli I, et al. Analysis of the horizontal corneal diameter, central corneal thickness, and axial length in premature infants. Arq Bras Oftalmol. 2014;77(4):225–227.
  • Gonçalves E, Násser L, Martelli D, et al. Incidence and risk factors for retinopathy of prematurity in a Brazilian reference service. Sao Paulo Med J. 2014;132(2):85–91.
  • Caner I, Tekgunduz KS, Temuroglu A, et al. Evaluation of premature infants hospitalized in neonatal intensive care unit between 2010-2012. Eurasian J Med. 2015;47(1):13–20.
  • Adio A, Ugwu R, Nwokocha C, et al. Retinopathy of prematurity in Port Harcourt, Nigeria. ISRN Ophthalmol. 2014;2014:1–6.
  • Uchida A, Miwa M, Shinoda H, et al. Association of maternal age to development and progression of retinopathy of prematurity in infants of gestational age under 33 weeks. J Ophthalmol. 2014;2014:1–5.
  • Erol MK, Ozdemir O, Coban DT, et al. Macular findings obtained by spectral domain optical coherence tomography in retinopathy of prematurity. Int Ophthalmol. 2014;2014(4):1–600.
  • Liu Q, Yin Z-Q, Ke N, et al. Incidence of retinopathy of prematurity in southwestern China and analysis of risk factors. Med Sci Monit. 2014;20:1442–1451.
  • Sohaila A, Tikmani S, Khan I, et al. Frequency of retinopathy of prematurity in premature neonates with a birth weight below 1500 grams and a gestational age less than 32 weeks: a study from a tertiary care hospital in a lower-middle income country. PLoS One. 2014;9(7):e100785–e100794.
  • Port A, Chan R, Ostmo S, et al. Risk factors for retinopathy of prematurity: insights from outlier infants. Graefes Arch Clin Exp Ophthalmol. 2014;252(10):1669–1677.
  • Tsai L, Chen Y, Tsou K, et al. The impact of small-for-gestational-age on neonatal outcome among very-low-birth-weight infants. Pediatr Neonatol. 2015;56(2):101–107.
  • PéRez-Munuzuri A, Couce-Pico ML, Bana-Souto A, et al. Preclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum. PLoS One. 2014;9(2):e88781–:e88787.
  • Katar S, Ta.Kesen M, Ekmekçiler B, et al. Incidence and risk factors for retinopathy in premature infants with very low birth weight, in the South-East Region, Turkey. JCP. 2014;12(3):140–143.
  • Fernández R, Apremont I, Domínguez A, et al. Survival and morbidity of very low birth weight infants in a South American Neonatal Network. Arch Argent Pediatr. 2014;112(5):405–412.
  • Choi JY, Han YI, Kim JH, et al. The most important factors for retinopathy of prematurity in preterm infants. Korean J Perinatol. 2014;25(3):153–158.
  • Omer IM, Hassan HA. The prevalence and risk factors of retinopathy of prematurity among preterm babies admitted to Soba Neonatal Intensive Care Unit. Sudan J Paediatr. 2014;14(2):17–21.
  • Chen S, Lin Y, Lu C, et al. Changes in outcome and complication rates of very-low-birth-weight infants in one tertiary center in southern Taiwan between 2003 and 2010. Pediatr Neonatol. 2014;55(4):291–296.
  • Li M-L, Hsu S-M, Chang Y-S, et al. Retinopathy of prematurity in southern Taiwan: a 10-year tertiary medical center study. J Formos Med Assoc. 2013;112(8):445–453.
  • Sabzehei M, Afjeh S, Dastjani-Farahani A, et al. Retinopathy of prematurity: incidence, risk factors, and outcome. Arch Iran Med. 2013;16(9):507–512.
  • Mohamed S, Murray JC, Dagle JM, et al. Hyperglycemia as a risk factor for the development of retinopathy of prematurity. BMC Pediatr. 2013;13(1):1–5.
  • Peirovifar A, Gharehbaghi MM, Gharabaghi PM, et al. Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity. Singapore Med J. 2013;54(12):709–712.
  • Kong X, Xu F, Wu R, et al. Neonatal mortality and morbidity among infants between 24 to 31 complete weeks: a multicenter survey in China from 2013 to 2014. BMC Pediatr. 2016;16(1):1–8.
  • Mohamed-Ali N, George J, Joshi N, et al. Prevalence of retinopathy of prematurity in Brunei Darussalam. Int J Ophthalmol. 2013;6(3):381–384.
  • Abrishami M, Maemori G-A, Boskabadi H, et al. Incidence and risk factors of retinopathy of prematurity in Mashhad, Northeast Iran. Iran Red Crescent Med J. 2013;15(3):229–233.
  • Abdel A, Hamdy I. Correlation between risk factors during the neonatal period and appearance of retinopathy of prematurity in preterm infants in neonatal intensive care units in Alexandria, Egypt. Clin Ophthalmol. 2013;7:831–837.
  • Lara-Molina N, Ramírez-Ortiz M, Ríos-Medina S, et al. Screening program in Michoacán State for retinopathy of prematurity. Gac Med Mex. 2013;149(3):280–285.
  • Akkoyun İ, İnce DA, Yılmaz G. Incidence of type-1 retinopathy of prematurity in premature babies born small for gestational age. TJO. 2013;43(5):340–344.
  • Sorge A, Schalij-Delfos N, Kerkhoff F, et al. Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria. Br J Ophthalmol. 2013;97(9):1143–1147.
  • Xu Y, Zhou X, Zhang Q, et al. Screening for retinopathy of prematurity in China: a neonatal units-based prospective study. Invest Ophthalmol Vis Sci. 2013;54(13):8229–8236.
  • Woo SJ, Park KH, Lee SY, et al. The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study. Invest Ophthalmol Vis Sci. 2013;54(5):3434–3439.
  • Saeidi R, Taraghi B, Saeidi M. Incidence of retinopathy of prematurity (ROP) in low birth weight newborns. J Neonatol. 2017;8(4):102–106.
  • Gotru S, Ahlers-Schmidt C, Delmore P, et al. The absolute nucleated red blood cell (aNRBC) count at birth is not an indicator for retinopathy of prematurity (ROP). J Perinatol. 2013;33(1):21–24.
  • Pietrzyk J, Kwinta P, Bik-Multanowski M, et al. New insight into the pathogenesis of retinopathy of prematurity: assessment of whole-genome expression. Pediatr Res. 2013;73(4 Pt 1):476–483.
  • Hyland RM, Komlósi K, Alleman BW, et al. Infantile hemangiomas and retinopathy of prematurity: clues to the regulation of vasculogenesis. Eur J Pediatr. 2013;172(6):803–809.
  • Atalay D, Salihoğlu O, Can E, et al. Short-term outcomes of very low birth weight infants born at a tertiary care hospital, Istanbul, Turkey. Iran J Pediatr. 2013;23(2):205–521.
  • Van der Merwe SK, Freeman N, Bekker A, et al. Prevalence of and risk factors for retinopathy of prematurity in a cohort of preterm infants treated exclusively with non-invasive ventilation in the first week after birth. S Afr Med J. 2013;103(2):96–100.
  • Gharehbaghi M, Peirovifar A, Sadeghi K. Plasma leptin concentrations in preterm infants with retinopathy of prematurity (ROP). Iran J Neonatol. 2012;1(3):11–16.
  • Liu Y-S, Chen T-C, Yang C-H, et al. Incidence, risk factors, and treatment of retinopathy of prematurity among very low birth body weight infants. Taiwan J Ophthalmol. 2012;2(2):60–63.
  • Jiménez C, Valladares MS, Valassi yBV. Factores de riesgo asociados a retinopatيa del prematuro. Gaceta Médica de México. 2012;148:19–25.
  • Seydel KB, Fox LL, Glover SJ, et al. Plasma concentrations of parasite histidine-rich protein 2 distinguish between retinopathy-positive and retinopathy-negative cerebral malaria in Malawian children. J Infect Dis. 2012;206(3):309–318.
  • Bain L, Dudley R, Gould J, et al. Factors associated with failure to screen newborns for retinopathy of prematurity. J Pediatr. 2012;161(5):819–823.
  • Bigdeli H, Roohipoor R, Karkhaneh R, et al. Structural outcome of treated retinopathy of prematurity patients. Iran J Ophthalmol. 2012;24(1):56–65.
  • Afarid M, Hosseini H, Abtahi B. Screening for retinopathy of prematurity in south of Iran. Middle East Afr J Ophthalmol. 2012;19(3):277–281.
  • Feghhi M, Altayeb SMH, Haghi F, et al. Incidence of retinopathy of prematurity and risk factors in the South-Western Region of Iran. Middle East Afr J Ophthalmol. 2012;19(1):101–106.
  • Rüegger C, Hegglin M, Adams M, et al. Population based trends in mortality, morbidity and treatment for very preterm- and very low birth weight infants over 12 years. BMC Pediatr. 2012;12(1):1–12.
  • Waal C, Weisglas-Kuperus N, Goudoever J, et al. Mortality, neonatal morbidity and two year follow-up of extremely preterm infants born in the Netherlands in 2007. PLoS One. 2012;7(7):1–7.
  • Banjac L, Bokan V. Retinopathy of prematurity and serum level of insulin-like growth factor-1. Acta Clin Croat. 2012;51(2):209–213.
  • Yang C, Lien R, Yang P, et al. Analysis of incidence and risk factors of retinopathy of prematurity among very-low-birth-weight infants in North Taiwan. Pediatr Neonatol. 2011;52(6):321–326.
  • Kne.Evi S, Stojanovi N, Oros A, et al. Analysis of risk factors in the development of retinopathy of prematurity. Srp Arh Celok Lek. 2011;139(7–8):433–438.
  • Gu M-H, Jin J, Yuan T-M, et al. Risk factors and outcomes for retinopathy of prematurity in neonatal infants with a birth weight of 1,501-2,000 g in a Chinese neonatal unit. Med Princ Pract. 2011;20(3):244–247.
  • Li W-L, He L, Liu X-H, et al. Analysis of risk factors for retinopathy of prematurity. Int J Ophthalmol. 2011;4(6):631–633.
  • Mehmet S, Fusun A, Sebnem C, et al. One-year experience in the retinopathy of prematurity: frequency and risk factors, short-term results and follow-up. Int J Ophthalmol. 2011;4(6):634–640.
  • Ghaseminejad A, Niknafs P. Distribution of retinopathy of prematurity and its risk factors. Iran J Pediat. 2011;21(2):209–214.
  • Chen M, Çitil A, McCabe F, et al. Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity. Neonatology. 2011;99(2):125–132.
  • Gharaibeh A, Khassawneh M, Khriesat W, et al. Adopting western retinopathy of prematurity screening programs in eastern countries, are we screening properly? Middle East Afr J Ophthalmol. 2011;18(3):209–213.
  • Santos. AMNd, Guinsburg R, Almeida. MFBd, et al. Factors associated with red blood cell transfusions in very-low-birth-weight preterm infants in Brazilian neonatal units. BMC Pediatrics. 2015;15(113):1–8.
  • Kusuda T, Hikino S, Ohga S, et al. Genetic variation of vascular endothelial growth factor pathway does not correlate with the severity of retinopathy of prematurity. J Perinatol. 2011;31(4):246–250.
  • Goulart AL, de Morais MB, Kopelman BI. Impact of perinatal factors on growth deficits in preterm infants. Revista da Associação Médica Brasileira. 2011;57(3):269–275.
  • Kocabeyoğlu S, Kadayıfcılar S, Eldem B. Premature Retinopatisinde Klinik Seyir, Tedavinin Degerlendirilmesi ve ilislkili Risk Faktoِrlerinin Belirlenmesi. TJO. 2011;41(3):128–132.
  • Chen M, Allred E, Hecht J, et al. Placenta microbiology and histology and the risk for severe retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2011;52(10):7052–7058.
  • Stoinska B, Gadzinowski J. Neurological and developmental disabilities in ELBW and VLBW: follow-up at 2 years of age. J Perinatol. 2011;31(2):137–142.
  • Naderian G, Molavi-Vardanjani H, Hadipour M, et al. Prevalence and risk factors for retinopathy of prematurity in Isfahan. Bina J. 2010;15(3):208–212.
  • Filho J, Eckert G, Valiatti F, et al. The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP). Graefes Arch Clin Exp Ophthalmol. 2010;248(6):893–900.
  • Yildiz M, Karkucak M, Yakut T, et al. Lack of association of genetic polymorphisms of angiotensin-converting enzyme gene I/D and glutathione-S-transferase enzyme T1 and M1 with retinopathy of prematures. Genet Mol Res. 2010;9(4):2131–2139.
  • BayatMokhtari M, Pishva N, Attarzadeh A, et al. Incidence and risk factors of retinopathy of prematurity among preterm infants in Shiraz/Iran. Iran J Pediatr. 2010;20(3):303–307.
  • Wu W-C, Ong F, Kuo J, et al. Retinopathy of prematurity and maternal age. Retina. 2010;30(2):327–331.
  • Schumann RF, Barbosa ADM, Valete CO. Incidence and severity of retinopathy of prematurity and its association with morbidity and treatments instituted at Hospital Antonio Pedro from Universidade Federal Fluminense, between 2003 and 2005. Arq Bras Oftalmol. 2010;73(1):47–51.
  • Zayed M, Uppal A, Hartnett M. New-onset maternal gestational hypertension and risk of retinopathy of prematurity. Invest Ophthalmol Visual Sci. 2010;51(10):49–498388.
  • ShinsatoI RN, PaccolaII L, GonçalvesIII WA, et al. Frequency of retinopathy of prematurity at newborns at the Clinical Hospital, Ribeirão Preto Medical School, University of São Paulo. Arq Bras Oftalmol. 2010;73(1):60–65.
  • Tomé V, Vieira J, Oliveira L, et al. Study of retinopathy of prematurity in a university hospital. Arq Bras Oftalmol. 2011;74(4):279–282.
  • Fayyazi A, Heidarzadeh M, Fayzalahzadeh H, et al. Prevalence of retinopathy of prematurity in preterm infant hospitalized in Tabriz Alzahra Hospital's NICU. Pediatrics. 2008;30(4):63–66.
  • Fouladinezhad M, Motahari MM, Gharib MH, et al. the prevalence, intensity and some risk factors of retinopathy of premature newborns in Taleghani Hospital, Gorgan, Iran. J Gorgan Univ Med Sci. 2009;11(2):30.
  • Saeidi R, Hashemzadeh1 A, Ahmadi S, et al. Predisposing prevalence and factors of retinopathy of prematurity in very lowbirthweight infants discharged from NICU. Iran J Pediatr. 2009;19(1):59–63.
  • Lorenz B, Spasovska K, Elflein H, et al. Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefes Arch Clin Exp Ophthalmol. 2009;247(9):1251–1262.
  • Borroni C, Carlevaro C, Morzenti S, et al. Survey on retinopathy of prematurity (ROP) in Italy. Ital J Pediatr. 2013;39(43):43–47.
  • Macêdo-Pinheiro A, Andrino-da-Silva W, Glenda-Freitas-Bessa C, et al. Incidence and risk factors of retinopathy of prematurity in UniversityHospital Onofre Lopes, Natal (RN) – Brazil. Arq Bras Oftalmol. 2009;72(4):451–456.
  • Mohamed S, Schaa K, Cooper ME, et al. Genetic contributions to the development of retinopathy of prematurity. Pediatr Res. 2009;65(2):193–197.
  • Filho J, Eckert G, Valiatti F, et al. Prevalence of retinopathy of prematurity: an institutional cross-sectional study of preterm infants in Brazil. Rev Panam Salud Publica. 2009;26(3):216–220.
  • Filho JBF, Valiatti FB, Eckert GU, et al. Is being small for gestational age a risk factor for nretinopathy of prematurity? A study with 345 very low birth weight preterm infants. J Pediatr. 2009;85(1):48–54.
  • Sadeghi K, Heidary E, Hashemi F, et al. Incidence and risk factors of retinopathy of prematurity. Ophthalmology. 2008;30(2):73–77.
  • Bas AY, Demirel N, Koc E, et al. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. Br J Ophthalmol. 2018;102(12):1711–1716.
  • Esfahani MR, Karkhaneh R, Shokravi N. Assessment of retinopathy of prematurity among 150 premature neonates in Farabi eye hospital. Acta Medica Iranica. 2001;39(1):35–38.
  • Kann IC, Solevag AL. Economic and health consequences of non-invasive respiratory support in newborn infants: a difference-in-difference analysis using data from the Norwegian patient registry. BMC Health Serv Res. 2014;14(1):1–8.
  • Hernández M, Orduña C, Bosch V, et al. Retinopathy of prematurity in the Murcia region of Spain. Incidence and severity. Arch Soc Esp Oftalmol. 2008;83(7):423–428.
  • Taqui A, Syed R, Chaudhry T, et al. Retinopathy of prematurity: frequency and risk factors in a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc. 2008;58(4):186–190.
  • Ahmed A, Muslima H, Anwar KS, Khan NZ, et al. Retinopathy of prematurity in Bangladeshi neonates. J Trop Pediatr. 2008;54(5):333–339.
  • Misra A, Heckford E, Curley A, et al. Do current retinopathy of prematurity screening guidelines miss the early development of pre-threshold type 1 ROP in small for gestational age neonates? Eye. 2008;22(6):825–829.
  • Mansouri M, Kadivar M, Karkhaneh R, et al. Prevalence and risk factors of retinopathy of prematurity in very low birth weight or low gestational age infants. Bina J Ophthalmol. 2007;12(4):428–434.
  • Jun Y, Xiao-Juan Y, Ai-Hua L, et al. Diagnosis of retinopathy of premature infants by RetCam digital retinal camera. J Appl Clin Pediatr. 2007;22(10):764.
  • Rasoulinejad SA, Montazeri M. Retinopathy of prematurity in neonates and its risk factors: a seven year study in Northern Iran. Open Ophthalmol J. 2016;10:17–21.
  • Bonotto LB, Moreira ATR, Carvalho DS. Prevalence of retinopathy of prematurity in premature babies examined during the period 1992-1999, Joinville (SC): evaluation of associated risks – screening. Arq Bras Oftalmol. 2007;70(1):55–61.
  • Senthil K, Thasneemsuraiya SI, Soundharya S, et al. A study on association of maternal preeclampsia and … retinopathy of prematurity. JEMDS. 2016;5(91):6783–6785.
  • Lermann V, Filho JF, Procianoy R. The prevalence of retinopathy of prematurity in very low birth weight newborn infants. J Pediatr. 2006;82(1):27–32.
  • Argollo N, Lessa I, Ribeiro S, et al. Peso de nascimento como preditor para a gravidade da lesão da substância branca cerebral neonatal. Arq Neuro-Psiquiatr. 2006;‏ 64(2a):287–294.
  • Karkhaneh R, Esfahani MR, Ghojehzadeh L, et al. Incidence and risk factors of retinopathy of prematurity. Bina J Ophthalmol. 2005;11(1):81–90.
  • Shah V, Yeo C, Fams Ling Y, et al. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005;34(2):169–178.
  • Kennedy K, Wrage L, Higgins R, et al. Evaluating retinopathy of prematurity screening guidelines for 24- to 27-week gestational age infants. J Perinatol. 2014;34(4):311–318.
  • Lubetzky R, Stolovitch C, Dollberg S, et al. Nucleated red blood cells in preterm infants with retinopathy of prematurity. Pediatrics. 2005;116(5):e619–e624.
  • Fledelius H, Göte H, Greisen G, et al. Surveillance for retinopathy of prematurity in a Copenhagen high-risk sample 1999-2001. Has progress reached a plateau? Acta Ophthalmol Scand. 2004;82(1):32–37.
  • Fledelius H, Kjer B. Surveillance for retinopathy of prematurity in a Danish country. Epidemiological experience over 20 years. Acta Ophthalmol Scand. 2004;82(1):38–41.
  • O'Connor MT, Vohr BR, Tucker R, et al. Is retinopathy of prematurity increasing among infants less than 1250 g birth weight? J Perinatol. 2003;23(8):673–678.
  • Mathew M, Fern A, Hill R. Prematurity: are we screening too many babies? Eye. 2002;16(5):538–542.
  • Larsson E, Carle-Petrelius B, Cernerud G, et al. Incidence of ROP in two consecutive Swedish population based studies. Br J Ophthalmol. 2002;86(10):1122–1126.
  • Larsson E, Holmstrm G. Screening for retinopathy of prematurity: evaluation and modification of guidelines. Br J Ophthalmol. 2002;86(12):1399–1402.
  • Al-Amro SA, Al-Kharfi TM, Thabit AA, et al. Retinopathy of prematurity at a University Hospital in Riyadh, Saudi Arabia. Saudi Med J. 2003;24(7):720–724.
  • Delport S, Swanepoel J, Odendaal P, et al. Incidence of retinopathy of prematurity in very-low-birth-weight infants born at Kalafong Hospital, Pretoria. S Afr Med J. 2002;92(12):986–990.
  • Aggarwal R, Deorari AK, Azad RV, et al. Changing profile of retinopathy of prematurity. INC. 2002;65(2):193–197.
  • Riazi-Esfahani M, Alizadeh Y, Karkhaneh R, et al. Frequency and severity of retinopathy of prematurity: singleton versus multiple-births. Bina J Ophthalmol. 2007;12(4):421–427.
  • Zin A. The increasing problem of retinopathy of prematurity. Community Eye Health. 2001;14(40):58–59.
  • Theng J, Wong T, Ling Y. Refractive errors and strabismus in premature Asian infants with and without retinopathy of prematurity. Singapore Med J. 2000;41(8):393–397.
  • Al-Essa M, Azad R, Rashwan N. Threshold stage of retinopathy of prematurity: maternal and neonatal risk factors. Ann Saudi Med. 2000;20(2):129–131.
  • Fledelius H, Kjer B, Rosenberg T. Retinopathy of prematurity in a Copenhagen high-risk sample 1997-98. The allover surveillance for ROP appears more and more complete. Acta Ophthalmol Scand. 2000;78(3):362–365.
  • Nakshab M, Bayani G, Âa A, et al. Prevalence of retinopathy in premature neonates in neonatal intensive care unit of Boali Sina Hospital in 2001. J Mazandaran Univ Med Sci. 2003;13(39):63–70.
  • Dos Santos Motta MM, Fortes Filho JB, Coblentz J, et al. Multiple pregnancies and its relationship with the development of retinopathy of prematurity (ROP). Clin Ophthalmol. 2011;5(1):1783–1787.
  • Yang EM, Song ES, Choi YY. Comparison of oral ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants. J Pediatr. 2013;89(1):33–39.
  • Hsieh C-J, Liu J-W, Huang J-S, et al. Refractive outcome of premature infants with or without retinopathy of prematurity at 2 years of age: a prospective controlled cohort study. Kaohsiung J Med Sci. 2012;28(4):204–211.
  • Celebi ARC, Petricli IS, Hekimoglu E, et al. The incidence and risk factors of severe retinopathy of prematurity in extremely low birth weight infants in Turkey. Med Sci Monit. 2014;20:1647–1653.
  • Sato T, Kusaka S, Shimojo H, et al. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology. 2009;116(9):1599–1603.
  • Chou H-H, Chung M-Y, Zhou X-G, et al. Early erythropoietin administration does not increase the risk of retinopathy in preterm infants. Pediatr Neonatol. 2017;58(1):48–56.
  • Trifonova K, Slaveykov K, Mumdzhiev H, et al. Artificial reproductive technology – a risk factor for retinopathy of prematurity. Open Access Maced J Med Sci. 2018;6(11):2245–2249.
  • Razak A, Faden M. Association of small for gestational age with retinopathy of prematurity: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2020;105(3):270–278.
  • Boghossian NS, Geraci M, Edwards EM, et al. Morbidity and mortality in small for gestational age infants at 22 to 29 weeks’ gestation. Pediatrics. 2018;141(2):e20172533.
  • Dailey WA, Gryc W, Garg PG, et al. Frizzled-4 variations associated with retinopathy and intrauterine growth retardation: a potential marker for prematurity and retinopathy. Ophthalmology. 2015;122(9):1917–1923.
  • Au SC, Tang S-M, Rong S-S, Chen L-J, et al. Association between hyperglycemia and retinopathy of prematurity: a systemic review and meta-analysis. Sci Rep. 2015;5(1):1–6.
  • Randhawa RS. The insulin-like growth factor system and fetal growth restriction. Pediatr Endocrinol Rev. 2008;6(2):235–240.
  • Mitra S, Aune D, Speer CP, et al. Chorioamnionitis as a risk factor for retinopathy of prematurity: a systematic review and meta-analysis. Neonatology. 2014;105(3):189–199.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.